Medidata, CRIO Partnership Advances eSource Integration to Improve Data Quality and Trial Efficiency

Medidata has entered a strategic partnership with CRIO to streamline clinical trial data flow by directly integrating site-level eSource with enterprise data platforms, aiming to reduce manual processes and improve data accuracy across global studies.¹

The collaboration introduces a “plug-and-play” digital pipeline that automates the transfer of clinical data from CRIO’s eSource platform into the Medidata Platform, eliminating the need for custom integrations. By connecting site workflows directly with data management systems, the partnership is designed to address long-standing inefficiencies tied to manual data entry and fragmented systems.

According to the companies, the integrated solution is already supporting more than 2,500 research sites across approximately 30 countries, with growing adoption among studies focused on chronic conditions. One in four US research sites engaged in these trials is now leveraging the combined CRIO-Medidata ecosystem.

Driving data accuracy and operational efficiency

Early performance benchmarks from the partnership point to measurable improvements in both data quality and site efficiency. Automated “source-to-EDC” data transfer is delivering near 100% data accuracy, significantly reducing the need for queries and post-entry corrections. At the same time, sites are reporting up to 90% faster data entry through the ability to auto-populate electronic data capture (EDC) forms directly from source data.

These gains reflect a broader shift toward eSource-driven trial models, where data is captured once at the point of care and reused across systems, minimizing duplication and the risk of transcription errors.

“Our partnership with CRIO accelerates our strategy connecting site-level eSource and the Medidata Platform,” said Tom Doyle, chief technology officer at Medidata. “This will accelerate workflows for thousands of sites that are often overlooked by traditional integration models, ultimately bringing new therapies to patients faster.”

For clinical sites, the integration is intended to remove a persistent operational burden. Historically, sites have had to manually re-enter data across multiple systems, creating inefficiencies and increasing the likelihood of errors.

“For years, clinical sites have been forced to act as manual data bridges between systems, a process that can be time-intensive and prone to error,” said Jonathan Andrus, co-CEO at CRIO. “By integrating CRIO eSource directly with the Medidata Platform, we are eliminating this friction for over 2,500 sites globally, reducing complexity and making clinical research easier for sites.”

Bridging site operations and enterprise data systems

Beyond efficiency gains, the partnership reflects a broader industry effort to better align site operations with sponsor and CRO data strategies. By enabling seamless data flow from source to EDC, the integration supports real-time visibility into study data, allowing sponsors to make faster, more informed decisions during trial execution.

The companies emphasized that reducing technical complexity is a key component of adoption, particularly for smaller or resource-constrained sites that have historically struggled to implement advanced integrations. By offering a standardized, scalable connection, the solution is designed to expand access to high-quality digital workflows across a broader segment of the research ecosystem.

Industry perspective on eSource integration

Last month, Applied Clinical Trials spoke with CRIO’s Chief Innovation Officer, Mike Wenger, for an exclusive interview at the annual SCOPE Summit in Orlando, FL.²

Wenger explained how eSource adoption requires a nuanced understanding of site workflows, with different approaches needed for electronic health record (EHR)-based health systems versus protocol-driven research sites.

“One flavor of site eSource would be organizations that are maybe a cancer center, academic medical center, or hospital. They’re seeing patients as part of standard of care, and they’re also conducting research,” he said. “For other sites that are often referred to as independent research sites, dedicated research sites, SMOs, or site networks, they are not using an EHR as part of their day-to-day workflow. And so for those groups, they’re going to use a different flavor of eSource—something that I like to refer to as protocol-driven eSource.”

Expanding AI-enabled clinical development

The CRIO collaboration comes as Medidata continues to expand its broader platform strategy through additional partnerships focused on artificial intelligence (AI) and integrated clinical development.

In an earlier announcement from October 2025, Medidata extended its long-standing collaboration with Sanofi, expanding the use of its Patient, Data, and Study Experiences solutions to support AI-enabled clinical trials. The partnership is designed to replace standalone tools with a more unified, AI-embedded platform experience.³

As part of the agreement, Sanofi is leveraging Medidata’s capabilities in decentralized clinical trials, reflecting a continued shift toward more flexible and patient-centric study designs.

Together, these initiatives highlight the industry’s focus on connecting data, workflows, and advanced analytics across the clinical development lifecycle, with eSource integration playing an increasingly central role in enabling faster, higher-quality trials.

References

1. Medidata and CRIO Empower Over 2,500 Global Research Sites with Seamless Integration to Accelerate Clinical Trials. News release. March 4, 2026. Accessed March 4, 2026. https://clinicalresearch.io/blog/medidata-and-crio-empower-over-2500-global-research-sites-with-seamless-integration-to-accelerate-clinical-trials/

2. SCOPE Summit 2026: Understanding the Different Flavors of eSource. Applied Clinical Trials. February 5, 2026. Accessed March 4, 2026. https://www.appliedclinicaltrialsonline.com/view/scope-summit-2026-understanding-esource

3. Medidata, BioRender Announce New AI Partnerships Expanding Capabilities in Life Sciences. Applied Clinical Trials. October 24, 2025. Accessed March 4, 2026. https://www.appliedclinicaltrialsonline.com/view/medidata-biorender-announce-new-ai-partnerships-expanding-capabilities-life-sciences